CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Shares withheld for taxes CHIEF STRATEGY OFFICER gave up 846 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,303 shares (to pay taxes)
- 4 Planned sale CHAIRMAN & CEO sold 7,278 shares at $50.01 ($363,973)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,208 shares (to pay taxes)
- 4 Planned sale CHIEF OPERATING OFFICER sold 2,367 shares at $48.58 ($114,989)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)
- 4 Planned sale Director sold 6,901 shares at $50.00 ($345,050)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF STRATEGY OFFICER gave up 1,756 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 2,510 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 10,313 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 2,821 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,706 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 3,205 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 36,722 shares at an average $45.92 ($1,686,158)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 4 of 39 · 778 filings